Dermatology
Latest News
Who’s Behind Cosmetic Procedures at MedSpas?
Researchers enlisted help from "secret shoppers" who contacted MedSpas to ask about the level of training, if patients underwent a review of...
Pediatric Dermatology Consult
A 7-Month-Old Female Presented With Nail Changes
The parents reported no history of trauma to the nails.
From the Journals
Chronic Back Pain in Patients With Psoriasis, Uveitis, or Colitis: How Often Is It Axial Spondyloarthritis?
A substantial proportion of patients with psoriasis, uveitis, or colitis and undiagnosed chronic back pain had axial spondyloarthritis, a study...
From the Journals
US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives
Use of infliximab biosimilars in the United States rose slowly until three were on the market; it continued to remain lower for Medicare than for...
Latest News
Nonmelanoma Skin Cancer: Encouraging Data on Laser Treatment
Data was strongest for the use of lasers for treating basal cell carcinoma, especially pulsed-dye lasers.
Latest News
Nemolizumab Benefits Seen in Adults, Teens With Atopic Dermatitis
Significant improvements in pruritus were observed as early as week 1, with a greater proportion of participants in the nemolizumab vs placebo...
Latest News
Recommendations From a Pediatric Dermatologist on Using AI in Daily Practice
Many academic institutions are creating “walled gardens” — private areas of AI access that don’t allow patient information to “leak out.”
From the Journals
Can Addressing Depression Reduce Chemo Toxicity in Older Adults?
Researchers evaluated whether greater reductions in grade 3 chemotherapy-related toxicities occurred with geriatric assessment-driven...
Latest News
Management, Evaluation of Chronic Itch in Older Adults
A malignancy workup should be strongly considered in patients whose itch duration is less than 12 months -- and especially if the duration is less...
Latest News
Study Links Melasma With Comorbidities, Races, Ethnicities
Among those with melasma, 25% had hypertension and 24% used hormonal contraception, the two most commonly associated risk factors identified.
Latest News
Case Series: Upadacitinib Effective for Granulomatous Cheilitis
Treatment resulted in a complete response in four patients within a median of 3.8 months and a partial response in one patient.